1iyj › Citations

BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.

Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thoma NH, Zheng N, Chen PL, Lee WH, Pavletich NP
Science 297 1837-48 (2002)
Related entries: 1miu, 1mje

Cited: 435 times
EuropePMC logo PMID: 12228710

Abstract

Mutations in the BRCA2 (breast cancer susceptibility gene 2) tumor suppressor lead to chromosomal instability due to defects in the repair of double-strand DNA breaks (DSBs) by homologous recombination, but BRCA2's role in this process has been unclear. Here, we present the 3.1 angstrom crystal structure of a approximately 90-kilodalton BRCA2 domain bound to DSS1, which reveals three oligonucleotide-binding (OB) folds and a helix-turn-helix (HTH) motif. We also (i) demonstrate that this BRCA2 domain binds single-stranded DNA, (ii) present its 3.5 angstrom structure bound to oligo(dT)9, (iii) provide data that implicate the HTH motif in dsDNA binding, and (iv) show that BRCA2 stimulates RAD51-mediated recombination in vitro. These findings establish that BRCA2 functions directly in homologous recombination and provide a structural and biochemical basis for understanding the loss of recombination-mediated DSB repair in BRCA2-associated cancers.

Reviews - 1iyj mentioned but not cited (4)

  1. Nucleic acid recognition by OB-fold proteins. Theobald DL, Mitton-Fry RM, Wuttke DS. Annu Rev Biophys Biomol Struct 32 115-133 (2003)
  2. The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination. Zhao W, Wiese C, Kwon Y, Hromas R, Sung P. Annu Rev Biochem 88 221-245 (2019)
  3. Roles of OB-Fold Proteins in Replication Stress. Nguyen DD, Kim EY, Sang PB, Chai W. Front Cell Dev Biol 8 574466 (2020)
  4. The phospho-dependent role of BRCA2 on the maintenance of chromosome integrity. Ehlén Å, Sessa G, Zinn-Justin S, Carreira A. Cell Cycle 20 731-741 (2021)

Articles - 1iyj mentioned but not cited (9)



Reviews citing this publication (131)

  1. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Annu Rev Biochem 73 39-85 (2004)
  2. ATM and related protein kinases: safeguarding genome integrity. Shiloh Y. Nat Rev Cancer 3 155-168 (2003)
  3. Mechanism of eukaryotic homologous recombination. San Filippo J, Sung P, Klein H. Annu Rev Biochem 77 229-257 (2008)
  4. Regulation of DNA double-strand break repair pathway choice. Shrivastav M, De Haro LP, Nickoloff JA. Cell Res 18 134-147 (2008)
  5. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Roy R, Chun J, Powell SN. Nat Rev Cancer 12 68-78 (2011)
  6. Molecular views of recombination proteins and their control. West SC. Nat Rev Mol Cell Biol 4 435-445 (2003)
  7. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Moynahan ME, Jasin M. Nat Rev Mol Cell Biol 11 196-207 (2010)
  8. The Fanconi anaemia/BRCA pathway. D'Andrea AD, Grompe M. Nat Rev Cancer 3 23-34 (2003)
  9. Homologous recombination in DNA repair and DNA damage tolerance. Li X, Heyer WD. Cell Res 18 99-113 (2008)
  10. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. Ashworth A. J Clin Oncol 26 3785-3790 (2008)
  11. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Wang W. Nat Rev Genet 8 735-748 (2007)
  12. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Prakash R, Zhang Y, Feng W, Jasin M. Cold Spring Harb Perspect Biol 7 a016600 (2015)
  13. The many faces of the helix-turn-helix domain: transcription regulation and beyond. Aravind L, Anantharaman V, Balaji S, Babu MM, Iyer LM. FEMS Microbiol Rev 29 231-262 (2005)
  14. Mechanism of homologous recombination: mediators and helicases take on regulatory functions. Sung P, Klein H. Nat Rev Mol Cell Biol 7 739-750 (2006)
  15. How the fanconi anemia pathway guards the genome. Moldovan GL, D'Andrea AD. Annu Rev Genet 43 223-249 (2009)
  16. Regulation and mechanisms of mammalian double-strand break repair. Valerie K, Povirk LF. Oncogene 22 5792-5812 (2003)
  17. Homologous recombination and its regulation. Krejci L, Altmannova V, Spirek M, Zhao X. Nucleic Acids Res 40 5795-5818 (2012)
  18. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T, Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia WH, Kolonel LN, Kooperberg C, Küry S, Lacroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu XO, Slattery ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng YX, Zhang B, Zheng W, Hsu L, Colon Cancer Family Registry and the Genetics and Epidemiology of Colorectal Cancer Consortium. Gastroenterology 144 799-807.e24 (2013)
  19. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Thompson LH. Mutat Res 751 158-246 (2012)
  20. Susceptibility pathways in Fanconi's anemia and breast cancer. D'Andrea AD. N Engl J Med 362 1909-1919 (2010)
  21. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Jasin M. Oncogene 21 8981-8993 (2002)
  22. Collaboration and competition between DNA double-strand break repair pathways. Kass EM, Jasin M. FEBS Lett 584 3703-3708 (2010)
  23. Plasmodium biology: genomic gleanings. Aravind L, Iyer LM, Wellems TE, Miller LH. Cell 115 771-785 (2003)
  24. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Powell SN, Kachnic LA. Oncogene 22 5784-5791 (2003)
  25. DNA strand break repair and human genetic disease. McKinnon PJ, Caldecott KW. Annu Rev Genomics Hum Genet 8 37-55 (2007)
  26. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Tutt A, Ashworth A. Trends Mol Med 8 571-576 (2002)
  27. From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold. Bochkarev A, Bochkareva E. Curr Opin Struct Biol 14 36-42 (2004)
  28. Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes. Ranjha L, Howard SM, Cejka P. Chromosoma 127 187-214 (2018)
  29. Oncogenes and tumor suppressor genes. Lee EY, Muller WJ. Cold Spring Harb Perspect Biol 2 a003236 (2010)
  30. Assembly, structure, and function of the 26S proteasome. Bedford L, Paine S, Sheppard PW, Mayer RJ, Roelofs J. Trends Cell Biol 20 391-401 (2010)
  31. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Venkitaraman AR. Annu Rev Pathol 4 461-487 (2009)
  32. The DNA damage response pathways: at the crossroad of protein modifications. Huen MS, Chen J. Cell Res 18 8-16 (2008)
  33. Replication protein A: directing traffic at the intersection of replication and repair. Oakley GG, Patrick SM. Front Biosci (Landmark Ed) 15 883-900 (2010)
  34. Tracing the network connecting BRCA and Fanconi anaemia proteins. Venkitaraman AR. Nat Rev Cancer 4 266-276 (2004)
  35. Oligonucleotide/oligosaccharide-binding fold proteins: a growing family of genome guardians. Flynn RL, Zou L. Crit Rev Biochem Mol Biol 45 266-275 (2010)
  36. Shieldin - the protector of DNA ends. Setiaputra D, Durocher D. EMBO Rep 20 e47560 (2019)
  37. Unraveling the mechanism of BRCA2 in homologous recombination. Holloman WK. Nat Struct Mol Biol 18 748-754 (2011)
  38. BRCA2: a universal recombinase regulator. Thorslund T, West SC. Oncogene 26 7720-7730 (2007)
  39. Rho-associated coiled-coil kinase (ROCK) signaling and disease. Schofield AV, Bernard O. Crit Rev Biochem Mol Biol 48 301-316 (2013)
  40. DNA damage response--a double-edged sword in cancer prevention and cancer therapy. Tian H, Gao Z, Li H, Zhang B, Wang G, Zhang Q, Pei D, Zheng J. Cancer Lett 358 8-16 (2015)
  41. Regulation of DNA strand exchange in homologous recombination. Holthausen JT, Wyman C, Kanaar R. DNA Repair (Amst) 9 1264-1272 (2010)
  42. PCI complexes: Beyond the proteasome, CSN, and eIF3 Troika. Pick E, Hofmann K, Glickman MH. Mol Cell 35 260-264 (2009)
  43. Choreography of recombination proteins during the DNA damage response. Lisby M, Rothstein R. DNA Repair (Amst) 8 1068-1076 (2009)
  44. The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. Crossan GP, Patel KJ. J Pathol 226 326-337 (2012)
  45. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Thompson LH, Hinz JM, Yamada NA, Jones NJ. Environ Mol Mutagen 45 128-142 (2005)
  46. RAD51, genomic stability, and tumorigenesis. Richardson C. Cancer Lett 218 127-139 (2005)
  47. Single-stranded DNA-binding proteins: multiple domains for multiple functions. Dickey TH, Altschuler SE, Wuttke DS. Structure 21 1074-1084 (2013)
  48. Multiple human single-stranded DNA binding proteins function in genome maintenance: structural, biochemical and functional analysis. Richard DJ, Bolderson E, Khanna KK. Crit Rev Biochem Mol Biol 44 98-116 (2009)
  49. Functional assays for analysis of variants of uncertain significance in BRCA2. Guidugli L, Carreira A, Caputo SM, Ehlen A, Galli A, Monteiro AN, Neuhausen SL, Hansen TV, Couch FJ, Vreeswijk MP, ENIGMA consortium. Hum Mutat 35 151-164 (2014)
  50. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Moynahan ME. Oncogene 21 8994-9007 (2002)
  51. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective. Sandhu SK, Yap TA, de Bono JS. Eur J Cancer 46 9-20 (2010)
  52. Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. Nagaraju G, Scully R. DNA Repair (Amst) 6 1018-1031 (2007)
  53. The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Paul A, Paul S. Front Biosci (Landmark Ed) 19 605-618 (2014)
  54. Disordered proteinaceous machines. Fuxreiter M, Tóth-Petróczy Á, Kraut DA, Matouschek A, Lim RY, Xue B, Kurgan L, Uversky VN. Chem Rev 114 6806-6843 (2014)
  55. Structural biology of innate immunity. Yin Q, Fu TM, Li J, Wu H. Annu Rev Immunol 33 393-416 (2015)
  56. DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing. Xue C, Greene EC. Trends Genet 37 639-656 (2021)
  57. Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Ralhan R, Kaur J, Kreienberg R, Wiesmüller L. Cancer Lett 248 1-17 (2007)
  58. BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Neff RT, Senter L, Salani R. Ther Adv Med Oncol 9 519-531 (2017)
  59. Role of BRCA Mutations in the Modulation of Response to Platinum Therapy. Mylavarapu S, Das A, Roy M. Front Oncol 8 16 (2018)
  60. Structural basis of homologous recombination. Sun Y, McCorvie TJ, Yates LA, Zhang X. Cell Mol Life Sci 77 3-18 (2020)
  61. Genomic instability and cancer: networks involved in response to DNA damage. Eyfjord JE, Bodvarsdottir SK. Mutat Res 592 18-28 (2005)
  62. DNA recombination, chromosomal stability and carcinogenesis: insights into the role of BRCA2. Shivji MK, Venkitaraman AR. DNA Repair (Amst) 3 835-843 (2004)
  63. RAD51 Gene Family Structure and Function. Bonilla B, Hengel SR, Grundy MK, Bernstein KA. Annu Rev Genet 54 25-46 (2020)
  64. Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study. Golan T, Raitses-Gurevich M, Kelley RK, Bocobo AG, Borgida A, Shroff RT, Holter S, Gallinger S, Ahn DH, Aderka D, Apurva J, Bekaii-Saab T, Friedman E, Javle M. Oncologist 22 804-810 (2017)
  65. PALB2: the hub of a network of tumor suppressors involved in DNA damage responses. Park JY, Zhang F, Andreassen PR. Biochim Biophys Acta 1846 263-275 (2014)
  66. Human single-stranded DNA binding proteins are essential for maintaining genomic stability. Ashton NW, Ashton NW, Bolderson E, Cubeddu L, O'Byrne KJ, Richard DJ. BMC Mol Biol 14 9 (2013)
  67. Fanconi anemia. Green AM, Kupfer GM. Hematol Oncol Clin North Am 23 193-214 (2009)
  68. Single-molecule imaging brings Rad51 nucleoprotein filaments into focus. Forget AL, Kowalczykowski SC. Trends Cell Biol 20 269-276 (2010)
  69. Structure and function of the double-strand break repair machinery. Shin DS, Chahwan C, Huffman JL, Tainer JA. DNA Repair (Amst) 3 863-873 (2004)
  70. Role of homologous recombination in DNA interstrand crosslink repair. Hinz JM. Environ Mol Mutagen 51 582-603 (2010)
  71. The homologous recombination system of Ustilago maydis. Holloman WK, Schirawski J, Holliday R. Fungal Genet Biol 45 Suppl 1 S31-9 (2008)
  72. BRCA gene structure and function in tumor suppression: a repair-centric perspective. Murphy CG, Moynahan ME. Cancer J 16 39-47 (2010)
  73. Cell biology of mitotic recombination. Lisby M, Rothstein R. Cold Spring Harb Perspect Biol 7 a016535 (2015)
  74. Dual role of CDKs in DNA repair: to be, or not to be. Yata K, Esashi F. DNA Repair (Amst) 8 6-18 (2009)
  75. Localization of checkpoint and repair proteins in eukaryotes. Lisby M, Rothstein R. Biochimie 87 579-589 (2005)
  76. Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network. Greenberg RA. Chromosoma 117 305-317 (2008)
  77. The Fanconi anemia pathway and ubiquitin. Jacquemont C, Taniguchi T. BMC Biochem 8 Suppl 1 S10 (2007)
  78. A growing network of cancer-susceptibility genes. Venkitaraman AR. N Engl J Med 348 1917-1919 (2003)
  79. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention. Gasch C, Ffrench B, O'Leary JJ, Gallagher MF. Mol Cancer 16 43 (2017)
  80. The interplay of Fanconi anemia proteins in the DNA damage response. Wang X, D'Andrea AD. DNA Repair (Amst) 3 1063-1069 (2004)
  81. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy. Motegi A, Murakawa Y, Takeda S. Cancer Lett 283 1-9 (2009)
  82. BRCA2 functions: from DNA repair to replication fork stabilization. Fradet-Turcotte A, Sitz J, Grapton D, Orthwein A. Endocr Relat Cancer 23 T1-T17 (2016)
  83. Ontologies for proteomics: towards a systematic definition of structure and function that scales to the genome level. Lan N, Montelione GT, Gerstein M. Curr Opin Chem Biol 7 44-54 (2003)
  84. The DNA double-strand break response pathway: becoming more BRCAish than ever. Ting NS, Lee WH. DNA Repair (Amst) 3 935-944 (2004)
  85. The development of PARP inhibitors in ovarian cancer: from bench to bedside. Drew Y. Br J Cancer 113 Suppl 1 S3-9 (2015)
  86. BRCA2 and pancreatic cancer. Naderi A, Couch FJ. Int J Gastrointest Cancer 31 99-106 (2002)
  87. From meiosis to postmeiotic events: uncovering the molecular roles of the meiosis-specific recombinase Dmc1. Kagawa W, Kurumizaka H. FEBS J 277 590-598 (2010)
  88. How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility? Venkitaraman AR. DNA Repair (Amst) 81 102668 (2019)
  89. Structural biology of the PCI-protein fold. Ellisdon AM, Stewart M. Bioarchitecture 2 118-123 (2012)
  90. DNA damage response and repair: insights into strategies for radiation sensitization of gliomas. Kesari S, Advani SJ, Lawson JD, Kahle KT, Ng K, Carter B, Chen CC. Future Oncol 7 1335-1346 (2011)
  91. Quality control of homologous recombination. Liu T, Huang J. Cell Mol Life Sci 71 3779-3797 (2014)
  92. Single nucleotide polymorphisms in DNA repair genes and putative cancer risk. Köberle B, Koch B, Fischer BM, Hartwig A. Arch Toxicol 90 2369-2388 (2016)
  93. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment. Toland AE, Andreassen PR. J Med Genet 54 721-731 (2017)
  94. From systems to structure: bridging networks and mechanism. Fraser JS, Gross JD, Krogan NJ. Mol Cell 49 222-231 (2013)
  95. Meiotic recombination in Caenorhabditis elegans. Garcia-Muse T, Boulton SJ. Chromosome Res 15 607-621 (2007)
  96. Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer. Hollis RL, Churchman M, Gourley C. Onco Targets Ther 10 2539-2551 (2017)
  97. Exploring the roles of PALB2 at the crossroads of DNA repair and cancer. Pauty J, Rodrigue A, Couturier A, Buisson R, Masson JY. Biochem J 460 331-342 (2014)
  98. Genetic variations in colorectal cancer risk and clinical outcome. Zhang K, Civan J, Mukherjee S, Patel F, Yang H. World J Gastroenterol 20 4167-4177 (2014)
  99. Breast cancer susceptibility testing: past, present and future. Goldberg JI, Borgen PI. Expert Rev Anticancer Ther 6 1205-1214 (2006)
  100. Structural disorder and its role in proteasomal degradation. Aufderheide A, Unverdorben P, Baumeister W, Förster F. FEBS Lett 589 2552-2560 (2015)
  101. Molecular Trajectory of BRCA1 and BRCA2 Mutations. Hatano Y, Tamada M, Matsuo M, Hara A. Front Oncol 10 361 (2020)
  102. Defects in homologous recombination repair behind the human diseases: FA and HBOC. Katsuki Y, Takata M. Endocr Relat Cancer 23 T19-37 (2016)
  103. Cycling with BRCA2 from DNA repair to mitosis. Lee H. Exp Cell Res 329 78-84 (2014)
  104. Genetic instability in inherited and sporadic leukemias. Popp HD, Bohlander SK. Genes Chromosomes Cancer 49 1071-1081 (2010)
  105. Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches. Farolfi A, Gurioli G, Fugazzola P, Burgio SL, Casanova C, Ravaglia G, Altavilla A, Costantini M, Amadori A, Framarini M, Ansaloni L, De Giorgi U. Int J Mol Sci 20 E2569 (2019)
  106. Molding BRCA2 function through its interacting partners. Martinez JS, Baldeyron C, Carreira A. Cell Cycle 14 3389-3395 (2015)
  107. Advances in structural studies of recombination mediator proteins. Korolev S. Biophys Chem 225 27-37 (2017)
  108. Misrepair in Context: TGFβ Regulation of DNA Repair. Liu Q, Lopez K, Murnane J, Humphrey T, Barcellos-Hoff MH. Front Oncol 9 799 (2019)
  109. Guardians of the Genome: BRCA2 and Its Partners. Le HP, Heyer WD, Liu J. Genes (Basel) 12 1229 (2021)
  110. Multiple interlinked mechanisms to circumvent DNA replication roadblocks. Eppink B, Wyman C, Kanaar R. Exp Cell Res 312 2660-2665 (2006)
  111. Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses. Andreassen PR, Seo J, Wiek C, Hanenberg H. Genes (Basel) 12 1034 (2021)
  112. HRness in Breast and Ovarian Cancers. Santana Dos Santos E, Lallemand F, Petitalot A, Caputo SM, Rouleau E. Int J Mol Sci 21 E3850 (2020)
  113. Archaeal genome guardians give insights into eukaryotic DNA replication and damage response proteins. Shin DS, Pratt AJ, Tainer JA. Archaea 2014 206735 (2014)
  114. Synthetic lethality: the road to novel therapies for breast cancer. Dhillon KK, Bajrami I, Taniguchi T, Lord CJ. Endocr Relat Cancer 23 T39-55 (2016)
  115. BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis. Li Q, Engebrecht J. Front Cell Dev Biol 9 668309 (2021)
  116. BRCA2 in meiosis: turning over a new leaf. Gudmundsdottir K, Ashworth A. Trends Cell Biol 14 401-404 (2004)
  117. Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors. Kelso AA, Waldvogel SM, Luthman AJ, Sehorn MG. Front Microbiol 8 1716 (2017)
  118. Biochemical attributes of mitotic and meiotic presynaptic complexes. Crickard JB, Greene EC. DNA Repair (Amst) 71 148-157 (2018)
  119. Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules. Jimenez-Sainz J, Jensen RB. Genes (Basel) 12 780 (2021)
  120. The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families. Fierheller CT, Alenezi WM, Tonin PN. Cancers (Basel) 13 3406 (2021)
  121. The role of the Fanconi anemia network in the response to DNA replication stress. Gari K, Constantinou A. Crit Rev Biochem Mol Biol 44 292-325 (2009)
  122. BRCA2: one small step for DNA repair, one giant protein purified. Jensen RB. Yale J Biol Med 86 479-489 (2013)
  123. Repair of DNA double-strand breaks in plant meiosis: role of eukaryotic RecA recombinases and their modulators. Emmenecker C, Mézard C, Kumar R. Plant Reprod 36 17-41 (2023)
  124. Roles of homologous recombination in response to ionizing radiation-induced DNA damage. Nickoloff JA, Sharma N, Allen CP, Taylor L, Allen SJ, Jaiswal AS, Hromas R. Int J Radiat Biol 99 903-914 (2023)
  125. Intrinsic Disorder and Phosphorylation in BRCA2 Facilitate Tight Regulation of Multiple Conserved Binding Events. Julien M, Ghouil R, Petitalot A, Caputo SM, Carreira A, Zinn-Justin S. Biomolecules 11 1060 (2021)
  126. OB-fold Families of Genome Guardians: A Universal Theme Constructed From the Small β-barrel Building Block. Bianco PR. Front Mol Biosci 9 784451 (2022)
  127. [Functions of PALB2 and BRCA2 tumor suppressors in DNA double-strand break repair]. Buisson R, Masson JY. Med Sci (Paris) 29 301-307 (2013)
  128. [Genetic bases of the radiosensitivity of breast cancer]. Delaloge S, Marsiglia H. Cancer Radiother 9 77-86 (2005)
  129. BRCA Mutations-The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers. Loboda AP, Adonin LS, Zvereva SD, Guschin DY, Korneenko TV, Telegina AV, Kondratieva OK, Frolova SE, Pestov NB, Barlev NA. Int J Mol Sci 24 4982 (2023)
  130. Missense Variants of Uncertain Significance: A Powerful Genetic Tool for Function Discovery with Clinical Implications. Sessa G, Ehlén Å, von Nicolai C, Carreira A. Cancers (Basel) 13 3719 (2021)
  131. Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations. Yan S, Imam M. Discov Oncol 14 110 (2023)

Articles citing this publication (291)



Quick links